Prospects for a prophylactic HPV vaccine: Rationale and future implications for cervical cancer screening

Mark E. Sherman, Mark H. Schiffman, Howard Strickler, Allan Hildesheim

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Cytologic screening in combination with ablative therapy has helped reduce cervical cancer mortality in the developed world. Despite the success of this approach, cervical cancer remains a major cause of death, especially among women with limited access to health care. Recognition that human papillomaviruses (HPVs) are the main etiologic agent in cervical cancer suggests that a prophylactic vaccine could reduce the incidence of HPV infection and, therefore, achieve cancer control with reduced reliance on costly screening programs. In this review, the rationale for developing a prophylactic HPV vaccine and the potential impact that vaccination would have on cervical cancer screening are discussed.

Original languageEnglish (US)
Pages (from-to)5-9
Number of pages5
JournalDiagnostic Cytopathology
Volume18
Issue number1
DOIs
StatePublished - 1998

Keywords

  • Cervix
  • Cytology
  • Papillomavirus
  • Vaccine
  • VLP

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Fingerprint Dive into the research topics of 'Prospects for a prophylactic HPV vaccine: Rationale and future implications for cervical cancer screening'. Together they form a unique fingerprint.

  • Cite this